The US Food and Drug Administration (FDA) India office invited officials of drug regulators, both at Central and State government levels, to accompany its team inspecting pharmaceutical units in the country.
This is subsequent to a memorandum of understanding that the two countries inked during the visit of US FDA Commissioner to India in February 2014, according to Soloman Yimam, Assistant Country Director, US FDA India Office.
“Based on that MoU, whenever we do GMP (good manufacturing practice) inspections we invite DCGI (Drug Controller General of India) officials and State regulators to accompany us on the inspections,” he said on Wednesday. Mr. Yimam, speaking on the sidelines of the BioAsia 2015 event here, was responding to a query on whether government of India has made requests to allow its officials to be present during inspections by FDA. Many in the pharmaceutical industry also favour this.
On whether the agreement was being practised, Mr. Yimam said: “There might be some glitches here and there, but it is something we always strive for… to bring them [Indian officials] on board. [We want them] to come with us, do the inspection, observe so that they can learn from our processes.”
Mr.Yimam, who addressed sessions at the Bio Asia on Tuesday as well as Wednesday, said the US FDA in India operates out of New Delhi and Mumbai. It was looking to increase the headcount to 19. It has 8 inspectors now.
You have reached your limit for free articles this month.
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Personalised recommendations
A select list of articles that match your interests and tastes.
Faster pages
Move smoothly between articles as our pages load instantly.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Briefing
We brief you on the latest and most important developments, three times a day.
Support Quality Journalism.
*Our Digital Subscription plans do not currently include the e-paper, crossword and print.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
Please Email the Editor